Need more? Try out  Advanced Search (20+ criteria)»

logo

Last Update

This profile was last updated on 5/22/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong M. First?

M. Roy First

Vice President and Therapeutic Area Head of Transplantation

Astellas Pharma US , Inc.

HQ Phone:  (800) 695-4321

Direct Phone: (224) ***-****direct phone

Email: m***@***.com

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Astellas Pharma US , Inc.

1 Astellas Way

Northbrook, Illinois,60062

United States

Company Description

Astellas Pharma US, Inc., located in Northbrook, Illinois, is a U.S. affiliate of Tokyo-based Astellas Pharma Inc. Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliabl... more

Find other employees at this company (3,058)

Background Information

Employment History

Chief Medical Officer

Transplant Genomics Inc


President

American Society of Transplant Physicians


Assistant Professor of Medicine In the Division of Nephrology

University of Cincinnati


Chairman

SAB


Affiliations

Michael Reese Hospital

Renal Research Fellow


Organ Donation Committee

Committee


Education

University of Witwatersrand


M.D.


advanced degrees

medicine

South Africa


Web References(63 Total References)


Leadership - Transplant Genomics

transplantgenomics.com [cached]

Dr. Roy First - Chief Medical Officer
M. Roy First, M.D. was Vice President and Global Therapeutic Area Leader, Transplantation at Astellas Pharma Global Development, Inc. After graduating from medical school at the University of Witwatersrand in Johannesburg, South Africa, he moved to Chicago in 1972 to take the position of Renal Research Fellow at the Michael Reese Hospital. Read More In 1974, he was appointed Assistant Professor of Medicine in the Division of Nephrology at the University of Cincinnati, later becoming full Professor and Director of the Section of Transplantation, a position that he held until 2002, when he moved to Fujisawa (later Astellas). During his distinguished academic career, Dr. First has published more than 390 articles on transplantation, as well as 39 book chapters and two books. He is a past President of the American Society of Transplant Physicians (ASTP, subsequently AST) and has served on many United Network for Organ Sharing (UNOS) committees, including chairing the Organ Donation Committee, on the Center for Drug Evaluation and Research (CDER) of the Food and Drug Administration (FDA), as a reviewer for the National Institutes of Health (NIH), on the NIH Data Safety and Monitoring Board for Clinical Trials in Transplantation, and as a Councilor of the Transplantation Society. Dr. First has been on the editorial board of a number of journals including Transplantation, Transplantation Proceedings, Clinical Transplantation, the American Journal of Transplantation, and the Journal of the American Society of Nephrology. In 2013 he received the AST Lifetime Achievement Award.


Leadership - Transplant Genomics

transplantgenomics.com [cached]

Dr. Roy First - Chief Medical Officer
M. Roy First, M.D. was Vice President and Global Therapeutic Area Leader, Transplantation at Astellas Pharma Global Development, Inc. After graduating from medical school at the University of Witwatersrand in Johannesburg, South Africa, he moved to Chicago in 1972 to take the position of Renal Research Fellow at the Michael Reese Hospital. Read More In 1974, he was appointed Assistant Professor of Medicine in the Division of Nephrology at the University of Cincinnati, later becoming full Professor and Director of the Section of Transplantation, a position that he held until 2002, when he moved to Fujisawa (later Astellas). During his distinguished academic career, Dr. First has published more than 390 articles on transplantation, as well as 39 book chapters and two books. He is a past President of the American Society of Transplant Physicians (ASTP, subsequently AST) and has served on many United Network for Organ Sharing (UNOS) committees, including chairing the Organ Donation Committee, on the Center for Drug Evaluation and Research (CDER) of the Food and Drug Administration (FDA), as a reviewer for the National Institutes of Health (NIH), on the NIH Data Safety and Monitoring Board for Clinical Trials in Transplantation, and as a Councilor of the Transplantation Society. Dr. First has been on the editorial board of a number of journals including Transplantation, Transplantation Proceedings, Clinical Transplantation, the American Journal of Transplantation, and the Journal of the American Society of Nephrology. In 2013 he received the AST Lifetime Achievement Award.


CTI Finds Niche In The Quest for Cures - Cincinnati Enquirer

communityresearch.com [cached]

Roy First, vice president and therapeutic area head of transplantation for Astellas Pharma Global Development in Northbrook, Ill., says Schroeder and CTI have developed a solid reputation in their specialty niches, especially transplant medicine.
Where Life-changing Therapies Turn First®


Dr. Roy First Joins Transplant Genomics as Chief Medical Officer - Transplant Genomics

transplantgenomics.com [cached]

Dr. Roy First Joins Transplant Genomics as Chief Medical Officer
Back to All Press Releases Dr. Roy First Joins Transplant Genomics as Chief Medical Officer Company Readies for Commercial Launch of TruGraf™ Blood Test for the Diagnosis of Rejection Following Kidney Transplantation Brookline, MA, April 30, 2015 - Transplant Genomics Inc. (TGI) has announced the appointment of Dr. Roy First as its Chief Medical Officer as the company moves toward the launch of its first product, the TruGraf Blood Test. Most recently, Dr. First was the Vice President and Therapeutic Area Leader, Transplantation, at Astellas Pharma Global Development, Inc. He is a past President of the American Society of Transplantation (AST) and recipient of the AST Lifetime Achievement Award. His distinguished clinical and academic career includes professional appointments at major academic institutions and importantroles in many organizations, such as the United Network for Organ Sharing, the U.S. Food and Drug Administration and the National Institutes of Health. "I am very excited to be joining this innovative company on the cutting edge of applying genomic biomarkers to post-transplant management," commented Dr. First. "The ultimate goal is to be able to detect and respond to early signs of graft injury so as to improve management of the patient as well as graft outcomes. I am convinced that TruGraf has such capabilities and has the potential to extend graft and patient lives, and reduce healthcare costs." "Roy is a widely respected leader in transplantation with a deep understanding of the field, and we are thrilled to have him join our team," explained Stan Rose, PhD, President & CEO of Transplant Genomics.


Staff, Author at Nephrology News & Issues - Page 3 of 97

www.nephrologynews.com [cached]

Transplant Genomics hires Roy First, MD, as CMO
Staff, May 22, 2015 Transplant Genomics has appointed transplant physician Roy First, MD, as its chief medical officer as the company moves toward the launch of its first product, the TruGraf Blood Test


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory